Quality of life after patient-initiated versus physician-initiated response to symptom monitoring: the SYMPRO-Lung trial.
Billingy NE, N M F Tromp V, Aaronson NK, Hoek RJA, Bogaard HJ, Onwuteaka-Philipsen BD, van de Poll-Franse L, Hugtenburg JG, Belderbos J, Becker-Commissaris A, van den Hurk CJG, Walraven I; SYMPRO-Lung Consortium.
Billingy NE, et al. Among authors: van den hurk cjg.
J Natl Cancer Inst. 2023 Aug 21:djad159. doi: 10.1093/jnci/djad159. Online ahead of print.
J Natl Cancer Inst. 2023.
PMID: 37603720